[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"smoking-tobacco\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:smoking-tobacco":73},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,55,89,112,139,171,192,216],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":32,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":54},"100557265","the-efficacy-of-conventional-screening-versus-mhealth-screening-in-early-detection-of-oral-potentially-malignant-disorders-and-oral-cancer-amongst-the-rural-population-of-varanasi-a-prospective-and-blinded-study-100557265",false,"NCT06535867","The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study","Inclusion Criteria:\n\nPositive for any one or more of the following:\n\n* All individuals aged above 18 years positive for habits (smoking and smokeless tobacco, chewing betel leaf, areca nut, paan masala, and\u002For regular use of alcohol)\n* Clinical signs\u002Fsymptoms (non-healing ulcers, white\u002F red\u002Fred \\& white patches in the mouth, restriction of mouth opening and swelling of the neck)\n* All individuals aged above 40 irrespective of habit\u002Foral lesions\n\nExclusion Criteria:\n\n* Individuals already diagnosed with oral cancer and undergoing treatment for oral cancer\n* Under treatment for tuberculosis or suffering from any acute illness\u002F debilitating systemic disorders",true,"ALL","18 Years",{"count":19,"type":20},5122,"ESTIMATED","OBSERVATIONAL","Mobile health (mHealth) will be used for early detection of oral cancer and pre-cancer lesions, and to improve awareness of oral cancer among the population and knowledge of oral cancer diagnosis among frontline health providers. This program is inclusive of long term surveillance to downstage oral cancer in India",[24,25,26,27,28,29,30,31],"Smoking","Smoking, Cigarette","Smoking, Tobacco","Betel Chewer's Mucosa","Tobacco Use","Tobacco Smoking","Alcohol Drinking","Smokeless Tobacco Hyperkeratosis",[33,34,35,36,37,38,39,40,41,42],"smoking","smoking, cigarette","smoking, tobacco","smokeless tobacco","betel leaf","areca nut","paan masala","alcohol use","Memorial Sloan Kettering Cancer Center","24-148","RECRUITING","2026-05-19",{"date":46,"type":47},"2026-05-22","ACTUAL",{"date":49,"type":47},"2024-07-30",{"date":51,"type":20},"2031-07-30",{"name":41,"class":53},"OTHER",1,{"id":56,"slug":57,"hasResults":11,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":63,"targetDuration":4,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":74,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":54},"100636653","tubsis-20---tobacco-use-behavioral-support-and-intervention-system-100636653","NCT07568483","TUBSIS 2.0 - Tobacco Use Behavioral Support and Intervention System","Effectiveness of an Internet-based, Self-help, Asynchronized Behavioral Therapy With Mindfulness Approach for Adults With Tobacco Smoking or Vaping to Support Adults in Reducing Tobacco Smoking and Vaping in Switzerland and Türkiye","TUBSIS_2_0","Inclusion Criteria:\n\n* Age: 18 years or older\n* Smoking status:\n\nSmoked on ≥1 day in the past 30 days, and\u002For Smoked at least 100 cigarettes in lifetime\n\n* Internet access: Stable internet connection and access to a smartphone, tablet, or computer during interaction of the TUBSIS 2.0 web-based platform.\n* Language: Sufficient reading and listening comprehension in the study language (German, English or Turkish)\n* Contact: Valid email address and phone number (optional) for study communication, reminders and incentive payments\n* Consent: Provided electronic informed consent on TUBSIS 2.0 web-based platform which is developed and administrated by ISGF.\n* Study procedures: Agreement to randomization (intervention or control) and completion of study assessments at four time points (baseline, mid-intervention, post-intervention and 8-week follow-up)\n\nExclusion Criteria:\n\n* Individuals who do not meet the inclusion criteria are excluded.",{"count":64,"type":20},406,"INTERVENTIONAL",[67],"NA","Background:\n\nTobacco smoking and vaping remains public health concern, with many adults continuing to experience difficulties accessing appropriate support for smoking cessation in Switzerland and Türkiye. Structural barriers, including stigma related to attempting to quit, limited financial and time resources, low awareness of the health risks associated with tobacco smoking- and vaping-reduce engagement with traditional services. TUBSIS 2.0 aims to address these access inequities by providing a fully remote, anonymous and free internet-based program tailored to diverse adult populations in both countries.\n\nObjectives:\n\nThe \"TUBSIS 2.0: An Adaptation Study of Tobacco Addiction Support Programme - TUBSIS for Tobacco Users in Switzerland and Türkiye\" project aims to support readiness to reduce or quit tobacco smoking\u002Fvaping, improve well-being and self-compassion and strengthen health-related behaviors. The intervention targets German-, English-, and Turkish-speaking adults and includes mindfulness-based strategies for quitting or reducing tobacco smoking and vaping. Motivation to cease tobacco smoking\u002Fvaping varies considerably across the lifespan. Younger individuals may perceive smoking\u002Fvaping cessation as unnecessary, often due to limited awareness of long-term health risks or a sense of invulnerability. In later adulthood, although addiction tends to be more deeply established, many individuals hesitate to attempt cessation because of concerns about the psychological and behavioral challenges associated with the process. It is therefore essential to provide individuals with support that helps them understand the cessation process, prepare for the challenges that can be expected and identify strategies that align with their psychological needs. Such strategies may include stress management and self-compassion practices that can be utilized before, during and after cessation attempts. TUBSIS 2.0 offers structured and accessible guidance to support this preparation by providing a clear, evidence-based pathway for individuals at different stages of readiness to change.\n\nMethods:\n\nTUBSIS 2.0 is a web-based, individual and asynchronous program consisting of eight modules delivered over four weeks. A total of 406 participants will be recruited and randomly assigned to either the intervention or control group. Data are collected anonymously at four measurement points (baseline, mid-term, post-term and 8-week follow-up) from participants. The program focuses on supporting participants' reducing or quitting tobacco smoking or vaping; to increase their readiness for smoking\u002Fvaping cessation, mental well-being, self-compassion and stress management with mindfulness strategies.\n\nWithin the Health Action Process Approach (HAPA), the process of behaviour change is conceptualised as a dynamic, non-linear process that progresses through motivational and volitional phases. TUBSIS 2.0 has been adapted to reflect this structure by integrating phase-specific components. These components include modules that enhance risk awareness and outcome expectancies, planning and self-regulation tools to support action initiation and mindfulness-based strategies that are embedded throughout all phases to strengthen self-efficacy and coping. By addressing these shifting needs across the change process, the programme provides a responsive and theory-driven pathway for reducing\u002Fquitting tobacco smoking or vaping.\n\nRelevance:\n\nTUBSIS 2.0 is highly relevant to public health priorities, as it provides a cost-effective, scalable and environmentally sustainable intervention that eliminates barriers commonly associated with traditional cessation services. By requiring no travel, printed materials or in-person appointments, the programme offers equitable access to adults across all age groups, genders and diverse migrant communities in Switzerland and Türkiye. Its multilingual and culturally adapted structure addresses significant service gaps for populations that are underserved or hesitant to seek conventional support. By reducing tobacco smoking- or vaping-related harm and facilitating early behavioural change, TUBSIS 2.0 has the potential to decrease long-term healthcare costs while expanding access to evidence-based digital prevention tools.",[70,71,72,73],"Tobacco Use Disorder","Nicotine Dependence","Vaping","Smoking Tobacco",[75,76,77,78,79],"smoking tobacco","vaping","web-based intervention","mindfulness","Health Action Process Approach","2026-04-30",{"date":82,"type":47},"2026-05-05",{"date":84,"type":47},"2025-11-15",{"date":86,"type":20},"2026-08-31",{"name":88,"class":53},"University of Zurich",{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":93,"acronym":4,"eligibilityCriteria":94,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":95,"targetDuration":4,"studyType":65,"phases":97,"briefSummary":98,"conditions":99,"keywords":4,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":54},"100490007","leveraging-community-pharmacists-to-optimize-smoking-cessation-services-for-rural-smokers-in-appalachia-100490007","NCT05660525","Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia","Study participants will be rural cigarette smokers from Virginia, Tennessee, Kentucky and North Carolina who visit one of the participating study pharmacies. Pharmacies will be located in rural geographic areas of the Central and South Central subregions of Appalachia that include Virginia, Tennessee, Kentucky and North Carolina, as defined by the USDA Rural-Urban Continuum Codes (RUCC) 4-9, Rural-Urban Commuting Area (RUCA) codes 4-10, or Frontier and Remote (FAR) areas level 4. No exclusionary criteria are based on race, gender, or age.\n\nInclusion Criteria include:\n\n* must be 18 years of age and older\n* must be able to read, speak, and understand English\n* must report smoking at least 5 cigarettes per day for the past 6 months (regardless of non-cigarette tobacco product use)\n* must be willing to set a quit date within the next 30 days\n* must own a cell phone\n* must be willing and able to use NRT in the form of patch or lozenge\n* Not be pregnant or planning to be pregnant in the next 6 months.\n\nExclusion Criteria include:\n\n* are pregnant women (self-reported), breastfeeding, planning to become pregnant during the next 6 months\n* have a medical contraindication to NRT (e.g., past 30 days, heart attack or stroke; past 6 months, serious or worsening angina, very rapid or irregular heartbeat requiring medication)",{"count":96,"type":20},768,[67],"The goal of this clinical trial is to evaluate the effectiveness and implementation of a pharmacist-delivered MTM (medication therapy management) approach, called QuitAid, to quitting cigarette smoking in rural Appalachia.\n\nThe main questions it aims to answer are:\n\n* Is QuitAid, alone or combined with other quitting tobacco treatments, effective?\n* What makes QuitAid easy or hard to carry out? Is it cost effective? Is it easy to maintain?\n\nTreatment:\n\nAll participants will be given at least 4 weeks of the nicotine patch.\n\nSome participants will be randomized (like the flip of a coin) to receive additional treatments (listed below).\n\nThese groups will be compared to each other to see which combination works best to help them quit smoking.\n\n* Smokefree TXT - a texting program that helps people quit smoking\n* Tobacco quitline - 4 phone sessions to help people quit smoking\n* 8 weeks of NRT (nicotine replacement therapy in the form of nicotine patches or nicotine patches and lozenge) medication instead of 4 weeks\n* QuitAid - An MTM program given by the patient's pharmacist. This is a quitting smoking coaching program\n* Nicotine patch AND nicotine lozenge instead of just nicotine patches",[100,25,101,24,26,102],"Smoking Cessation","Smoking Reduction","Quitting Smoking","2026-04-16",{"date":105,"type":47},"2026-04-20",{"date":107,"type":47},"2024-03-06",{"date":109,"type":20},"2028-03-01",{"name":111,"class":53},"University of Virginia",{"id":113,"slug":114,"hasResults":11,"nctId":115,"briefTitle":116,"officialTitle":117,"acronym":4,"eligibilityCriteria":118,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":119,"enrollmentInfo":120,"targetDuration":4,"studyType":65,"phases":122,"briefSummary":123,"conditions":124,"keywords":127,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":129,"lastUpdatePostDateStruct":130,"startDateStruct":132,"completionDateStruct":134,"leadSponsor":136,"locationsCount":138},"100588724","act-lung-health-intervention-phase-two-100588724","NCT06945120","ACT Lung Health Intervention: Phase Two","Efficacy of an Asian Culture-tailored Lung Health (ACT) Intervention on Lung Cancer Screening and Smoking Cessation in Asian Americans","Inclusion Criteria:\n\n* Self-identify as either Chinese or Korean\n* Speak either Korean, Mandarin, or English\n* Are 18 years of age or older\n* Are current smokers (i.e., have smoked at least 100 traditional cigarettes ever and have smoked at least one traditional cigarette within the prior 30 days)\n* Will live in the United States for the next 12 months\n\nExclusion Criteria:\n\n* Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months.\n* We will not include any of the following special populations:\n\n  * Adults unable to consent.\n  * Adults younger than 50 or older than 80 years\n  * Individuals who are not yet adults (infants, children, teenagers)\n  * Pregnant women\n  * Prisoners","100 Years",{"count":121,"type":20},50,[67],"This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.",[100,125,26,25,126],"Smoking Behaviors","Smoking (Tobacco) Addiction",[100,128,126,25,26,125],"Lung Cancer Screening","2026-03-11",{"date":131,"type":47},"2026-03-13",{"date":133,"type":47},"2025-11-04",{"date":135,"type":20},"2026-12-31",{"name":137,"class":53},"Dana-Farber Cancer Institute",2,{"id":140,"slug":141,"hasResults":11,"nctId":142,"briefTitle":143,"officialTitle":144,"acronym":4,"eligibilityCriteria":145,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":146,"targetDuration":4,"studyType":65,"phases":148,"briefSummary":149,"conditions":150,"keywords":152,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":163,"lastUpdatePostDateStruct":164,"startDateStruct":166,"completionDateStruct":168,"leadSponsor":170,"locationsCount":5},"100569396","a-study-evaluating-the-use-of-an-indoor-air-quality-monitor-to-promote-a-smoke-free-home-100569396","NCT06693700","A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home","Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families","Inclusion Criteria:\n\n* Adult (aged \\>18 years) MSK patients as per the EHR\n* Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database\n* Reports current (within the past 30 days) tobacco use (i.e., cigarettes and\u002For any other tobacco products) as per the TTP Intake form\n* Must be English-speaking in the EHR\n* Must be reachable by phone as per self-report\n* Must have Wi-Fi available at home as per self-report\n\nExclusion Criteria:\n\n* Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and\u002For per self-report",{"count":147,"type":20},10,[67],"The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.",[24,100,101,151,125,26,25,126,28,29],"Smoking Habit",[33,153,154,155,156,35,34,157,158,159,160,161,162,41],"smoking cessation","smoking reduction","smoking habit","smoking behaviors","smoking (tobacco) addiction","tobacco use","tobacco smoking","air quality","indoor air quality monitoring devices","24-260","2025-10-21",{"date":165,"type":47},"2025-10-22",{"date":167,"type":47},"2024-11-14",{"date":169,"type":20},"2027-11-14",{"name":41,"class":53},{"id":172,"slug":173,"hasResults":11,"nctId":174,"briefTitle":175,"officialTitle":176,"acronym":4,"eligibilityCriteria":177,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":178,"enrollmentInfo":179,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":181,"conditions":182,"keywords":4,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":186,"completionDateStruct":188,"leadSponsor":190,"locationsCount":54},"100595092","respiratory-function-and-oxygenation-in-smokers-and-non-smokers-100595092","NCT07027956","Respiratory Function and Oxygenation in Smokers and Non-smokers","A Comparison of Respiratory Function, Exercise Capacity and Oxygenation Between Smokers and Non-smokers","Inclusion Criteria (Smokers):\n\n* According to the World Health Organization and ICD smoking addiction criteria, consuming at least one cigarette every day for the last year\n* Volunteering to participate in research\n* Able to walk and cooperate\n\nExclusion Criteria (Smokers):\n\n* Having any cardiopulmonary disease\n* Having a musculoskeletal problem that could affect the tests\n* Failure to comply with tests\n\nInclusion Criteria (Non-smokers):\n\n* According to the World Health Organization and ICD smoking addiction criteria, having never smoked or not having smoked in the last year\n* Volunteering to participate in research\n* Able to walk and cooperate\n\nExclusion Criteria (Non-smokers):\n\n* Having any cardiopulmonary disease\n* Having a musculoskeletal problem that could affect the tests\n* Failure to comply with tests","65 Years",{"count":180,"type":20},42,"This study aimed to compare respiratory function, exercise capacity, and intercostal muscle oxygenation in healthy smokers and non-smokers.",[26],"2025-06-17",{"date":185,"type":47},"2025-06-19",{"date":187,"type":47},"2025-05-28",{"date":189,"type":20},"2025-12",{"name":191,"class":53},"Kirsehir Ahi Evran Universitesi",{"id":193,"slug":194,"hasResults":11,"nctId":195,"briefTitle":196,"officialTitle":197,"acronym":4,"eligibilityCriteria":198,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":199,"targetDuration":4,"studyType":65,"phases":201,"briefSummary":203,"conditions":204,"keywords":206,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":207,"lastUpdatePostDateStruct":208,"startDateStruct":210,"completionDateStruct":212,"leadSponsor":214,"locationsCount":138},"100499691","phase-3-vpsf-m-for-tobacco-cessation-in-hiv-care-in-india-100499691","NCT05786547","V+PSF-M for Tobacco Cessation in HIV Care in India","Varenicline and Mobile Behavioral Assistance for Tobacco Cessation in HIV Care in India","Inclusion Criteria:\n\n* Adults (≥18 years)\n* Confirmed HIV diagnosis\n* Self-reported current smoking or dual tobacco use verified either by exhaled carbon monoxide ≥7 ppm, or by positive qualitative cotinine point-of-care test\n* Able to read at 6th grade level or greater and speak Tamil, Telugu or English\n* Able to use varenicline safely based on evaluation by primary provider at VHS\n* Women of childbearing potential who consent to use a medically approved method of contraception or abstain from intercourse while taking study medication and for one month after.\n* Ready to quit or interested in quitting\n\nExclusion Criteria:\n\n* Pregnant or planning to become pregnant in the next 6 months\n* Breastfeeding\n* Myocardial infarction in past 30 days or unstable angina\n* History of liver or kidney failure\n* Alanine aminotransferase and Aspartate aminotransferase \\> 2 times upper limit of normal or creatinine clearance \\\u003C50 in past 6 months\n* History of suicide attempt\n* Current suicidal ideation\n* Untreated or unstable major depressive disorder\n* History of psychosis or on anti-psychotic medications\n* Cognitive impairment limiting ability to consent\n* Allergy to varenicline",{"count":200,"type":20},400,[202],"PHASE3","The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV).\n\nThe study interventions used in this research study are:\n\n* Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program)\n* Varenicline (or Chantix, apovarenicline, Champix or Nocrav)",[205,100,26],"Human Immunodeficiency Virus",[205,100,26],"2025-06-13",{"date":209,"type":47},"2025-06-15",{"date":211,"type":47},"2024-01-02",{"date":213,"type":20},"2026-07-22",{"name":215,"class":53},"University of Colorado, Denver",{"id":217,"slug":218,"hasResults":11,"nctId":219,"briefTitle":220,"officialTitle":220,"acronym":221,"eligibilityCriteria":222,"healthyVolunteers":11,"sex":16,"minAge":223,"maxAge":178,"enrollmentInfo":224,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":226,"conditions":227,"keywords":233,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":248,"lastUpdatePostDateStruct":249,"startDateStruct":251,"completionDateStruct":253,"leadSponsor":255,"locationsCount":138},"100515497","cue-effects-in-human-addiction-pavlovian-to-instrumental-transfer-100515497","NCT05992272","Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer","ReCoDe","Inclusion Criteria:\n\n* males and females between 16-65 years of age\n* AUD subjects only: meet a minimum of 2 criteria for DSM-5 alcohol-related disorder (AUD) (not requiring withdrawal as assessed by an independent psychiatrist) and AUDIT \\> 4\n* Smokers: Daily smokers only: smoke 7 days\u002Fweek during the last three months\n* Non-daily smokers only: smoke at least once but less than 7 days\u002Fweek during the last three months\n* Ability to consent to the study and complete the questionnaires\n* Sufficient language skills: German\n* Availability between 3pm-6pm on 2 consecutive days (Experiment 1, acute stress question)\n* Females only: luteal phase (Experiment 1, acute stress question)\n\nExclusion Criteria:\n\n* Lifetime diagnosis according to DMS-5 for: Bipolar disorder, schizophrenia, schizophrenia spectrum disorder, substance dependence except for alcohol, nicotine, or cannabis\n* Currently meeting DSM-5 diagnostic criteria for a depressive episode, suicidal ideation\n* Past traumatic brain injury or severe neurological disease (such as dementia, Parkinson's disease, multiple sclerosis)\n* Pregnancy or breastfeeding\n* Ingestion of medications known to interact with the CNS in the 10-day period prior to study participation or less than 4 half-lives after last ingestion (rapid urine test)\n* MR contraindications (e.g., pacemakers, metallic or electronic implants, metallic splinters, surgical staples)\n* Color vision deficiency\n* Sensorineural hearing loss of 30 dB or greater,\n* Tinnitus\n* Presence of claustrophobia\n* Acute alcohol intoxication at MRI appointments verified by breath alcohol testing or drug intoxication verified by rapid urine testing\n* For women only: not peri- or postmenopausal, not taking contraceptives (Experiment 1, acute stress question)","16 Years",{"count":225,"type":20},300,"Individuals with substance use disorders (SUD) have to cope with drug-related cues and contexts, which can affect instrumental drug seeking as shown with Pavlovian to instrumental transfer (PIT) paradigms in animals and humans. The investigators aimed to investigate the impact of acute and chronic stress on Pavlovian-to-instrumental transfer (PIT), how PIT it is associated with cognitive control abilities and whether such effects predict losing vs. regaining control in subjects with AUD. Moreover, the investigators aimed to develop a novel full transfer task that assesses both, general and specific PIT to investigate whether specific PIT differs between alcohol use disorder (AUD) and control subjects.",[228,229,230,26,231,232],"Alcohol Use Disorder (AUD)","Alcoholism","Substance Use Disorders","Stress Reaction","Stress",[234,235,236,237,238,239,240,241,242,243,244,245,246,247],"substance use disorder (SUD), cognitive control\u002Finterference","alcohol use disorder (AUD)","Smokers","general and outcome-specific Pavlovian to instrumental transfer","chronic and acute stress","Amygdala","Stroop Test","Ventral Striatum","Neuroimaging","Humans","Surveys and Questionnaires","Reward","Fractals","Cues","2024-08-20",{"date":250,"type":47},"2024-08-21",{"date":252,"type":47},"2020-11-24",{"date":254,"type":20},"2024-12-31",{"name":256,"class":53},"Charite University, Berlin, Germany"]